{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-283007","form_type":"8-K","ticker":"SMNR","cik":"0001913577","company_name":"Semnur Pharmaceuticals, Inc.","filed_at":"2026-06-25T21:03:49+00:00","discovered_at":"2026-06-25T21:06:00.379317+00:00","generated_at":"2026-06-25T21:06:19.677463+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Semnur stockholders elect director, ratify auditor, approve 2025 equity plans at annual meeting","bullets":["Jay Chun, M.D., Ph.D. elected Class I director with 200,166,258 for, 3,804 withheld, 137,409 broker non-votes.","Ratification of Pipara & Co LLP as auditor for FY 2026: 200,307,425 for, 46 against, 0 abstentions.","2025 Equity Incentive Plan approved: 200,166,256 for, 269 against, 3,537 abstentions, 137,409 broker non-votes.","2025 Employee Stock Purchase Plan approved: 200,166,255 for, 270 against, 3,537 abstentions, 137,409 broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-283007","json":"https://secwatch.observer/filing/0001193125-26-283007.json","markdown":"https://secwatch.observer/filing/0001193125-26-283007.md","text":"https://secwatch.observer/filing/0001193125-26-283007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1913577/000119312526283007/0001193125-26-283007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1913577/000119312526283007/smnr-20260625.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T21:06:19.677463+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}